Trial intelligence / Profile preview

Captopril versus carvedilol for hypertensive urgency

IRCT20200723048182N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of captopril and carvedilol in hypertension (HTN) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Started Sep 2019; status: completed.

02

Drugs

captoprilcarvedilol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on IRCT20200723048182N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200723048182N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call